Study shows that Long noncoding epidermal growth factor receptor (lnc-EGFR) can promote hepatocellular carcinoma growth by inducing Treg differentiation, which offering a potential therapeutic target for hepatocellular carcinoma [6]. Here, EGFR is linked to hepatocellular carcinoma.